T. Rowe Price Investment Management, Inc. Abbott Laboratories Transaction History
T. Rowe Price Investment Management, Inc.
- $163 Billion
- Q1 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 99,894 shares of ABT stock, worth $10.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
99,894
Previous 60,922
63.97%
Holding current value
$10.2 Million
Previous $6.71 Million
69.31%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ABT
# of Institutions
3,131Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.71M-
Vanguard Group Inc Valley Forge, PA165MShares$16.8 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.5 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.54 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.6 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.13 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $178B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...